← back to search

Anastasios Raptis

UPMC Hillman Cancer Center · US
Area of research
Hematology · Oncology
Research interest
Research interests include Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Hematopoietic Stem Cell Transplantation, and Neutropenia and Cancer Infections.
h-index
18
citations
2,019
works
99
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
The Lancet Haematology 2019cited by 241position: middledoi
Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Cytotherapy 2017cited by 179position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Cliona M. Rooney · Houston Methodist1 papers (2017–2017)Zhuyong Mei · Texas Children's Hospital1 papers (2017–2017)Annie Im · UPMC Hillman Cancer Center1 papers (2017–2017)Hong Wang · Universitat Politècnica de Catalunya1 papers (2017–2017)Jing‐Zhou Hou · Center for Cancer and Blood Disorders1 papers (2017–2017)Michael Boyiadzis · UPMC Hillman Cancer Center1 papers (2017–2017)Mounzer Agha · UPMC Hillman Cancer Center1 papers (2017–2017)Lisa H. Butterfield · University of San Francisco1 papers (2017–2017)Kathleen Dorritie · University of Pittsburgh1 papers (2017–2017)Robert L. Redner · UPMC Hillman Cancer Center1 papers (2017–2017)Seah H. Lim · Brown University1 papers (2017–2017)Natalia Lapteva · Texas Children's Hospital1 papers (2017–2017)Rafic Farah · UPMC Hillman Cancer Center1 papers (2017–2017)Theresa L. Whiteside · UPMC Hillman Cancer Center1 papers (2017–2017)Alison R. Sehgal · UPMC Hillman Cancer Center1 papers (2017–2017)